Search - tctmd.com

Displaying 381 - 399 of 399

Sort: Relevancy | Date

News Daily News

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

L.A. McKeown

August 16, 2011

News Daily News

PFO-Stroke Link Takes Another Hit

Jason Kahn

August 11, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Commentary Authors Urge Improvements to Device Approval Process

Caitlin E. Cox

July 20, 2011

News Daily News

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

June 24, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Industry News

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011

News Daily News

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

May 09, 2011

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Industry News

Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech

March 02, 2011

News Daily News

Early Morning Circadian Rhythms Linked to Stent Thrombosis

February 21, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Jason Kahn

February 09, 2011

News Industry News

Vascular Solutions Introduces the OptiSeal™ Valved Peelable Introducer

January 26, 2011

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

News Industry News

Boston Scientific to Acquire Atritech

January 18, 2011

News Industry News

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

January 16, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

January 04, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

Advertisement

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

PFO-Stroke Link Takes Another Hit

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Commentary Authors Urge Improvements to Device Approval Process

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

Myocardial Injury Common with TAVI, But Clinical Import Less Certain

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech

Early Morning Circadian Rhythms Linked to Stent Thrombosis

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Vascular Solutions Introduces the OptiSeal™ Valved Peelable Introducer

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Boston Scientific to Acquire Atritech

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content